Beta-Blockers for the Prevention of Acute Exacerbations of COPD
Sponsor: United States Department of Defense
Enrolling: Male and Female Patients
Study Length: 365 Days
Clinic Visits: 10
IRB Number: AAAQ9108
U.S. Govt. ID: NCT02587351
Contact: Sana Sajjad: 212-304-7969 /
Additional Study Information: The objective of the Block-COPD Study is to determine if beta-blockers are safe and effective at reducing the number of exacerbations or flare-ups that people living with Chronic Obstructive Pulmonary Disease (COPD) experience. A beta-blockers is a drug that is taken by mouth and is currently used to treat a wide range of diseases including high blood pressure and heart disease. The purpose of this study is to determine if this drug can also help patients with COPD. We hope that this study will help us learn more about how to treat COPD.
This study is closed
Keith Brenner, MD
Do You Qualify?
Have you ever been told by a doctor that you have chronic obstructive pulmonary disease (COPD) or emphysema Yes No
Have you had an exacerbation or a flare-up of your COPD symptoms within the last year Yes No
You may be eligible for this study

Place Holder

For more information, please contact:
Sana Sajjad